A better approach? Support the systems that regulate them naturally.

Across social media and encrypted messaging apps, a new frontier of weight loss is unfolding in real time, with people sourcing and injecting an experimental drug that regulators have not yet approved ...

A recent study of injectable pre-exposure prophylaxis found that twice-yearly injections of lenacapavir — marketed as Yeztugo by Gilead Sciences — do not have clinically significant interactions with ...